GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (HKSE:00853) » Definitions » YoY Rev. per Sh. Growth

MicroPort Scientific (HKSE:00853) YoY Rev. per Sh. Growth : 7.24% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is MicroPort Scientific YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. MicroPort Scientific's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 7.24%.

MicroPort Scientific's Revenue per Share for the six months ended in Dec. 2023 was HK$2.00.

MicroPort Scientific YoY Rev. per Sh. Growth Historical Data

The historical data trend for MicroPort Scientific's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific YoY Rev. per Sh. Growth Chart

MicroPort Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.23 -24.29 19.69 7.49 13.05

MicroPort Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.91 6.58 9.84 18.69 7.24

MicroPort Scientific YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

MicroPort Scientific's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(4.071-3.601)/ | 3.601 |
=13.05 %

MicroPort Scientific's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(2-1.865)/ | 1.865 |
=7.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort Scientific YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort Scientific (HKSE:00853) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (HKSE:00853) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
HKSE:02252 HKSE:01302 HKSE:01858 HKSE:02291 HKSE:09877 HKSE:06606 HKSE:01789 HKSE:02172 HKSE:02407 HKSE:09996 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
MCRPF:USA MSK:Germany
Address
1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203
Website
https://www.microport.com
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.
Executives
Shang Hai Zhang Jiang Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Maxwell Maxcare Science Foundation Limited 2201 Interest of corporation controlled by you
We'tron Capital Limited 2101 Beneficial owner
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hfty I Holdings Pte. Ltd. 2101 Beneficial owner
Otsuka Holdings Co., Ltd.
Otsuka Medical Devices Co., Ltd.
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

MicroPort Scientific (HKSE:00853) Headlines

No Headlines